Accenture Plc (ACN) Market Valuation Declined While Martin Investment Management Has Increased by $1.36 Million Its Holding; Shelton Capital Management Decreased Position in Gilead Sciences (GILD) by $1.91 Million

January 13, 2018 - By Adrian Erickson

Martin Investment Management Llc increased its stake in Accenture Plc (ACN) by 14.21% based on its latest 2017Q3 regulatory filing with the SEC. Martin Investment Management Llc bought 10,102 shares as the company’s stock declined 0.21% while stock markets rallied. The institutional investor held 81,187 shares of the business services company at the end of 2017Q3, valued at $10.97 million, up from 71,085 at the end of the previous reported quarter. Martin Investment Management Llc who had been investing in Accenture Plc for a number of months, seems to be bullish on the $98.74 billion market cap company. The stock increased 0.63% or $1 during the last trading session, reaching $160.11. About 2.05M shares traded or 9.90% up from the average. Accenture plc (NYSE:ACN) has risen 4.27% since January 13, 2017 and is uptrending. It has underperformed by 12.43% the S&P500.

Shelton Capital Management decreased its stake in Gilead Sciences Inc (GILD) by 11.62% based on its latest 2017Q3 regulatory filing with the SEC. Shelton Capital Management sold 23,600 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 179,411 shares of the health care company at the end of 2017Q3, valued at $14.54M, down from 203,011 at the end of the previous reported quarter. Shelton Capital Management who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $103.22 billion market cap company. The stock decreased 0.05% or $0.04 during the last trading session, reaching $79.02. About 6.37 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 13, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Shelton Capital Management, which manages about $1.01B and $1.29 billion US Long portfolio, upped its stake in Cisco Sys Inc (NASDAQ:CSCO) by 11,097 shares to 459,213 shares, valued at $15.44M in 2017Q3, according to the filing. It also increased its holding in Amgen Inc (NASDAQ:AMGN) by 2,809 shares in the quarter, for a total of 72,293 shares, and has risen its stake in Te Connectivity Ltd (NYSE:TEL).

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It increased, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. New York-based Edge Wealth Mgmt Ltd Co has invested 3.34% in Gilead Sciences, Inc. (NASDAQ:GILD). 360,893 were reported by Sei Invs. 131,154 are owned by Robecosam Ag. Palladium owns 6,660 shares or 0.04% of their US portfolio. Daiwa Sb Limited accumulated 380 shares or 0.01% of the stock. Evercore Wealth Ltd Limited Liability Company holds 0.17% or 53,861 shares in its portfolio. Nbt Bancorporation N A New York has 39,166 shares. Dynamic Capital Mgmt invested 1.55% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). The New Jersey-based Private Advisor Group Lc has invested 0.17% in Gilead Sciences, Inc. (NASDAQ:GILD). Citigroup Incorporated holds 0.09% or 1.36M shares in its portfolio. Barrett Asset Mngmt Ltd Limited Liability Company stated it has 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Capital Interest has 11.22M shares for 1.09% of their portfolio. Magellan Asset Mngmt Limited holds 180 shares. Trust Of Toledo Na Oh, a Ohio-based fund reported 29,035 shares. Lenox Wealth Mgmt Incorporated owns 10,392 shares.

Since August 1, 2017, it had 0 insider buys, and 11 insider sales for $41.13 million activity. MARTIN JOHN C had sold 73,333 shares worth $6.05 million on Monday, October 2. $4.99M worth of stock was sold by Meyers James R on Thursday, August 31. Washington Robin L sold $4.40M worth of stock or 51,820 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 111 analyst reports since July 29, 2015 according to SRatingsIntel. Citigroup maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, April 29 with “Buy” rating. On Monday, September 12 the stock rating was initiated by Berenberg with “Buy”. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, May 30 with “Buy” rating. Credit Suisse initiated Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, January 20. Credit Suisse has “Outperform” rating and $125 target. William Blair initiated the shares of GILD in report on Thursday, August 31 with “Buy” rating. The stock has “Hold” rating by Credit Suisse on Tuesday, September 5. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, October 4 report. The company was reinitiated on Tuesday, July 11 by Jefferies. The stock has “Overweight” rating by Piper Jaffray on Wednesday, February 3. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, July 25 report.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 earnings per share, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18B for 11.83 P/E if the $1.67 EPS becomes a reality. After $2.23 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Investors sentiment decreased to 1 in Q3 2017. Its down 0.05, from 1.05 in 2017Q2. It is negative, as 40 investors sold ACN shares while 370 reduced holdings. 97 funds opened positions while 315 raised stakes. 461.53 million shares or 1.06% less from 466.45 million shares in 2017Q2 were reported. Shine Invest Advisory Services invested in 1,732 shares. Maryland Management reported 3,127 shares stake. Douglass Winthrop Advsrs Ltd Liability Corp has invested 0.02% of its portfolio in Accenture plc (NYSE:ACN). Rhode Island-based Amica Retiree Med has invested 0.42% in Accenture plc (NYSE:ACN). Marathon Asset Mgmt Limited Liability Partnership holds 1.14% of its portfolio in Accenture plc (NYSE:ACN) for 511,671 shares. Deutsche Fincl Bank Ag holds 1.08 million shares or 0.1% of its portfolio. Moreover, State Board Of Administration Of Florida Retirement Sys has 0.33% invested in Accenture plc (NYSE:ACN) for 901,870 shares. Proshare Advsr Limited Company stated it has 57,892 shares or 0.07% of all its holdings. Wells Fargo & Mn holds 4.53 million shares. Huntington Savings Bank holds 0.56% of its portfolio in Accenture plc (NYSE:ACN) for 246,014 shares. Fernwood Mngmt Limited Liability stated it has 0.22% in Accenture plc (NYSE:ACN). Osborne Prns Mngmt Limited Liability Company has invested 1.12% of its portfolio in Accenture plc (NYSE:ACN). Monarch Capital holds 1.8% or 35,813 shares. Northstar Inv Advsr Lc holds 0.06% of its portfolio in Accenture plc (NYSE:ACN) for 2,100 shares. Cooke Bieler Ltd Partnership has 0.92% invested in Accenture plc (NYSE:ACN) for 367,769 shares.

Among 26 analysts covering Accenture Plc (NYSE:ACN), 14 have Buy rating, 1 Sell and 11 Hold. Therefore 54% are positive. Accenture Plc had 88 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was maintained by Pivotal Research with “Buy” on Friday, December 22. On Friday, July 28 the stock rating was maintained by Cowen & Co with “Buy”. Deutsche Bank maintained it with “” rating and $133 target in Monday, March 27 report. The firm has “Hold” rating given on Friday, June 16 by Morgan Stanley. The rating was maintained by Jefferies on Thursday, November 2 with “Hold”. The stock of Accenture plc (NYSE:ACN) earned “Outperform” rating by RBC Capital Markets on Friday, June 24. On Friday, May 20 the stock rating was maintained by Stifel Nicolaus with “Buy”. On Monday, October 3 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Susquehanna maintained it with “Hold” rating and $145.0 target in Tuesday, December 26 report. The rating was initiated by Cantor Fitzgerald on Friday, October 16 with “Buy”.

Martin Investment Management Llc, which manages about $585.57 million and $358.13M US Long portfolio, decreased its stake in Stryker Corp (NYSE:SYK) by 2,662 shares to 90,585 shares, valued at $12.87M in 2017Q3, according to the filing. It also reduced its holding in Berkshire Hathaway Inc (BRKB) by 21,342 shares in the quarter, leaving it with 61,414 shares, and cut its stake in Travelers Cos Inc/The (NYSE:TRV).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>